164 related articles for article (PubMed ID: 35544740)
1. National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey.
McBride A; Hudson-DiSalle S; Pilz J; Hamm M; Boring B; Buie LW; DeRemer DL
JCO Oncol Pract; 2022 Aug; 18(8):e1289-e1296. PubMed ID: 35544740
[TBL] [Abstract][Full Text] [Related]
2. National survey on the effect of oncology drug shortages on cancer care.
McBride A; Holle LM; Westendorf C; Sidebottom M; Griffith N; Muller RJ; Hoffman JM
Am J Health Syst Pharm; 2013 Apr; 70(7):609-17. PubMed ID: 23515514
[TBL] [Abstract][Full Text] [Related]
3. Effects on patient care caused by drug shortages: a survey.
McLaughlin M; Kotis D; Thomson K; Harrison M; Fennessy G; Postelnick M; Scheetz MH
J Manag Care Pharm; 2013; 19(9):783-8. PubMed ID: 24156647
[TBL] [Abstract][Full Text] [Related]
4. Impact of anti-cancer drugs shortages in oncology and hematology departments in a Moroccan hospital.
Cherif Chefchaouni A; Moutaouakkil Y; Adouani B; Tadlaoui Y; Lamsaouri J; Bousliman Y
J Oncol Pharm Pract; 2022 Jun; 28(4):822-826. PubMed ID: 33840285
[TBL] [Abstract][Full Text] [Related]
5. Impact of shortages of injectable oncology drugs on patient care.
Goldsack JC; Reilly C; Bush C; McElligott S; Bristol MN; Motanya UN; Field R; Vozniak JM; Wong YN; Schwartz JS; Domchek S
Am J Health Syst Pharm; 2014 Apr; 71(7):571-8. PubMed ID: 24644117
[TBL] [Abstract][Full Text] [Related]
6. The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology Group.
G Salazar E; Bernhardt MB; Li Y; Aplenc R; Adamson PC
Pediatr Blood Cancer; 2015 Jun; 62(6):940-4. PubMed ID: 25704486
[TBL] [Abstract][Full Text] [Related]
7. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
[TBL] [Abstract][Full Text] [Related]
8. Educational needs of oncology pharmacists: A survey by the International Society of Oncology Pharmacy Practitioners.
Patel H; Tan CJ; Toh YL; Danilak M; Alexander M
J Oncol Pharm Pract; 2021 Apr; 27(3):623-634. PubMed ID: 32539662
[TBL] [Abstract][Full Text] [Related]
9. Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners.
Chazan G; Jupp J; Bauters T; Duncan N; Weddle KJ; Nomura H; O'Connor S; Chan A; Alkhudair N; Alshamrani M; Buie LW; Chambers P; Chieh TW; DeRemer DL; Duvivier F; Katabalo D; McFarlane T; Mckavanagh D; Mensah K; Martinez EM; Rowan G; Sae-Teaw M; Tadesse TA; Weru I; Alexander M
J Oncol Pharm Pract; 2022 Dec; 28(8):1832-1847. PubMed ID: 34693814
[TBL] [Abstract][Full Text] [Related]
10. A Qualitative Analysis of Oncology Patient Awareness of Medication Shortages and Their Preferences for How Shortages Should Be Managed.
Hantel A; Hlubocky FJ; Siegler M; Daugherty CK
JCO Oncol Pract; 2020 Oct; 16(10):e1098-e1111. PubMed ID: 32469685
[TBL] [Abstract][Full Text] [Related]
11. Exploring practice site contributions and professionalization impact of engaging student pharmacists on hematology-oncology advanced pharmacy practice experience rotations.
Yacobucci MJ; Lombardi CL; Briceland LL
J Oncol Pharm Pract; 2022 Jan; 28(1):109-118. PubMed ID: 33470177
[TBL] [Abstract][Full Text] [Related]
12. Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey.
Griffin SP; Signorelli JR; Lasko A; Andrick BJ; Doan D; Hough S; Riebandt G; Harnicar S
J Oncol Pharm Pract; 2024 Mar; 30(2):332-341. PubMed ID: 37194276
[No Abstract] [Full Text] [Related]
13. Describing the role of the hematology/oncology clinical pharmacist in health information technology.
Philippon JS; Kusoski CL; Kennerly-Shah JM; Barreto JS
J Oncol Pharm Pract; 2021 Jan; 27(1):14-19. PubMed ID: 32306889
[TBL] [Abstract][Full Text] [Related]
14. Oncologists' experiences with drug shortages.
Kehl KL; Gray SW; Kim B; Kahn KL; Haggstrom D; Roudier M; Keating NL
J Oncol Pract; 2015 Mar; 11(2):e154-62. PubMed ID: 25549653
[TBL] [Abstract][Full Text] [Related]
15. Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice.
Przybylski DJ; Dow-Hillgartner EN; Reed MP; Fallon MJ
J Oncol Pharm Pract; 2020 Sep; 26(6):1374-1381. PubMed ID: 31937189
[TBL] [Abstract][Full Text] [Related]
16. Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology-oncology and transplant clinic: Assessment and significance.
Ali K; Al-Quteimat O; Naseem R; Malhi SM; Wajdi M; Jahan N; Ansari SH; Shamsi TS
J Oncol Pharm Pract; 2021 Jun; 27(4):815-820. PubMed ID: 32633660
[TBL] [Abstract][Full Text] [Related]
17. Development of a tool to allocate inpatient specialized pharmacy resources at a comprehensive cancer center.
Smith AT; Kennerly-Shah JM; Kusoski CL
J Oncol Pharm Pract; 2020 Oct; 26(7):1686-1694. PubMed ID: 32865162
[TBL] [Abstract][Full Text] [Related]
18. National survey of the impact of drug shortages in acute care hospitals.
Baumer AM; Clark AM; Witmer DR; Geize SB; Vermeulen LC; Deffenbaugh JH
Am J Health Syst Pharm; 2004 Oct; 61(19):2015-22. PubMed ID: 15509124
[TBL] [Abstract][Full Text] [Related]
19. Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists.
Gilbar P; Chambers CR; Larizza M
J Oncol Pharm Pract; 2015 Feb; 21(1):10-8. PubMed ID: 24418800
[TBL] [Abstract][Full Text] [Related]
20. Drug shortages may compromise patient safety: Results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists.
Said A; Goebel R; Ganso M; Zagermann-Muncke P; Schulz M
Health Policy; 2018 Dec; 122(12):1302-1309. PubMed ID: 30337159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
